Product Information
CLONAZEPAM 1 MG ODT is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.5634 per EA under NDC 00093929367. Its NADAC has been published 209 times since Jun 29, 2022.
Strength
1 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093929367
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077194On Market Since
11/22/2021
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 1 MG ODT has been published 209 times since Jun 29, 2022, and over the history we have for it it has declined 24.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5634 per EA |
|---|---|
| All-time high | $0.8268 (Nov 16, 2022) |
| All-time low | $0.4241 (Mar 22, 2023) |
| 52-week high | $0.6147 |
| 52-week low | $0.4879 |
| Median price | $0.5921 |
| Average price | $0.5930 |
| Largest weekly change | +48.7% (Jun 19, 2024) |
| Weeks tracked | 209 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 1 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 1 MG ODT, manufactured by Teva Pharmaceuticals USA Inc., is $0.5634 per EA (NDC 00093929367), effective Jun 24, 2026.
How has the price of CLONAZEPAM 1 MG ODT changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 1 MG ODT has declined 24.9%. It has been tracked across 209 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 1 MG ODT?
Since Jun 29, 2022, the NADAC for CLONAZEPAM 1 MG ODT has ranged from a low of $0.4241 (Mar 22, 2023) to a high of $0.8268 (Nov 16, 2022), with a median of $0.5921 per EA.
Are there cheaper alternatives to CLONAZEPAM 1 MG ODT?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CLONAZEPAM 1 MG TABLET, is $0.0250 per EA — about 96% below CLONAZEPAM 1 MG ODT.
Who manufactures CLONAZEPAM 1 MG ODT?
CLONAZEPAM 1 MG ODT (NDC 00093929367) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification